Independent Director · Revance Therapeutics, Inc. (RVNC)

Vlad Coric, M.D director compensation at Revance Therapeutics: $421K

Fiscal year 2023 director compensation for Vlad Coric, M.D at Revance Therapeutics, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed March 21, 2024 (DEF 14A). Open the filing on EDGAR.

Free

Get Vlad Coric, M.D’s full pay file as a PDF — free

More than this page: up to 10 years of Vlad’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Vlad Coric, M.D and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Revance Therapeutics Director Compensation Table · all 2 fiscal years held
In US dollars, as Revance Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2023$46,820$187,335$187,335$0$421,490
FY2022—————

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Revance Therapeutics, Inc. DEF 14A filed March 21, 2024, accession 0001479290-24-000071, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Revance Therapeutics, Inc. filed document, accession 0001479290-24-000071. Every figure is read from that document and cited to the page and table it appears in. Filed March 21, 2024.

Get the Revance Therapeutics Board Governance Report

$421,490 Vlad Coric, M.D, FY2023 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of March 21, 2024 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2023

Revance Therapeutics pays directors a $50,000 cash retainer and $225,000 in 50% RSAs / 50% Options.

Committees

FY2023 · as the proxy prints them

Compensation

The rest of the Revance Therapeutics board

FY2023 · as the company reported each
DirectorRoleFY2023 total
Angus C. RussellChair of the Board$346,033
Carey O'Connor KolajaIndependent Director$304,183
Christian W. NoletIndependent Director$315,033
Jill BeraudIndependent Director$317,533
Julian S. GangolliIndependent Director$305,033
Mark J. FoleyDirector—
Olivia C. WareIndependent Director$295,033

The full Revance Therapeutics compensation record

free company brief

This page is one director within Revance Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the Revance Therapeutics proxy · each links to its own free brief

Order RVNC

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report